David Westenberg

David A. Westenberg, a partner in the Corporate Practice Group of WilmerHale in Boston, is author of the acclaimed book Initial Public Offerings: A Practical Guide to Going Public (Practising Law Institute, October 2009).

Recent posts

FAST Act Offers More Goodies to Emerging Growth Companies
Once again proving that you can’t judge a gift by its box, emerging growth companies (EGCs) received a pleasant, but oddly wrapped, surprise in December with the enactment of a new... Read more »
JOBS Act: Important Benefits for Startups Not on the IPO On-Ramp
The JOBS Act is probably best-known for creating an “IPO on ramp” intended to reduce the cost and complexity of going public, but the act also contains important benefits for startups... Read more »
The JOBS Act—The “IPO On-Ramp” Makes IPOs Easier
Enacted with great fanfare in early April, the JOBS Act is intended to improve access to the public capital markets for startup companies. The cornerstone of the act is the creation... Read more »
From Main Street to Wall Street—10 Things a Startup Should Do to Groom Itself for an Eventual IPO
You’ve got the vision, the core team, and even a little money. You’re prepared to devote enormous time and energy to your new startup. You’re unsure what the future will bring... Read more »
Ready, Set, Go Public—The 10 Things You Need to Do Now
The IPO market is open for business. The IPO market window has slammed shut. Which is it? Unless your IPO is pricing in the next week or two, it doesn’t matter.... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Bay Area and Beyond: Biocom Talks Innovation and COVID
A Fireside Chat with Biocom President & CEO Joe Panetta
Biocom

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine

BioNTech's mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity

Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data

CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy

Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy

On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO

Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug

Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

The 2020 National Xconomy Awards

Xcelerating Life Sciences Seattle

Xcelerating Life Sciences New York

David Westenberg

Recent posts

FAST Act Offers More Goodies to Emerging Growth Companies

JOBS Act: Important Benefits for Startups Not on the IPO On-Ramp

The JOBS Act—The “IPO On-Ramp” Makes IPOs Easier

From Main Street to Wall Street—10 Things a Startup Should Do to Groom Itself for an Eventual IPO

Ready, Set, Go Public—The 10 Things You Need to Do Now

Underwriters and Partners

The Bay Area and Beyond: Biocom Talks Innovation and COVID

The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development

What to Include in Your Life Sciences Company Fundraising Pitch Deck

Xconomy on Demand

We offer a number of ways to subscribe for free!